Strategic partnerships Strata Oncology collaborates with major healthcare systems nationwide and routes patient biopsies to a high-throughput CLIA lab for rapid genomic sequencing, presenting a clear sales angle to expand alliance networks with health systems and hospital networks seeking precision oncology capabilities.

Rapid profiling Technology enables results within days, providing tumor profiles and therapy/trial matches to oncologists quickly; a compelling value proposition for patient access programs, payer discussions, and clinical decision support tool integrations.

Regulatory and security Adoption of AWS services and SOC 2 compliance signals a focus on secure, scalable cloud infrastructure, easing conversations with enterprise customers prioritizing data governance, security, and compliance in oncology data workflows.

Financial momentum Recent venture funding and growing revenue indicate a scalable business model with expansion potential; opportunities exist to partner on new clinical programs, co-development, or milestone-based collaborations with biotech and pharma stakeholders.

Clinical collaboration Strategic partnerships with pharmaceutical developers (example: Trodelvy access via PATH trial) and recognition for diagnostics innovation position Strata as a gateway for pharma-sponsored trials and companion diagnostic collaborations.